Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Radionuclide bone imaging

L W Bassett, R H Gold, M M Webber

Radiologic Clinics of North America

|December 1, 1981

Summary

This summary is machine-generated.

Radionuclide bone imaging using technetium-99m agents is crucial for detecting bone metastases and monitoring disease progression. This low-dose radioisotope scanning method is valuable for various skeletal conditions, including metastasis and osteomyelitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hot and not-so-hot females: reproductive state and thermal preferences of female Arizona Bark Scorpions (Centruroides sculpturatus).

Journal of evolutionary biology·2014

Same author

Retinoids, vitamin D, invasion, and metastasis.

Current oncology (Toronto, Ont.)·2012

Same author

Breast sonography.

Breast disease·2005

Same author

Mammographic findings of diffuse amyloidosis and carcinoma of the breast.

AJR. American journal of roentgenology·2001

Same author

Evaluation of the chemopreventive potential of retinoids using a novel in vitro human prostate carcinogenesis model.

Mutation research·2001

Same author

N-(4-hydroxyphenyl)retinamide (4-HPR) decreases neoplastic properties of human prostate cells: an agent for prevention.

Mutation research·2001

Same journal

Orbital Imaging.

Radiologic clinics of North America·2026

Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026

Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026

Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026

Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026

Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026

See all related articles

Area of Science:

Nuclear Medicine
Radiology
Oncology

Background:

Radionuclide bone imaging is a key diagnostic tool for skeletal conditions.
Detecting bone metastases and evaluating disease progression are critical in patient management.

Purpose of the Study:

To highlight the importance of radionuclide bone imaging for bone metastases.
To discuss the role of technetium-99m agents in radioisotope scanning.
To review applications in various bone diseases.

Main Methods:

Focus on technetium-99m agents for radionuclide bone imaging.
Utilizes low-dose radioisotope scanning techniques.
Evaluates diagnostic value in diverse skeletal conditions.

Main Results:

Related Experiment Videos

Radionuclide bone imaging is the primary method for detecting bone metastases.
It reliably assesses the progression or regression of metastatic bone disease.
Technetium-99m agents are valuable for widespread low-dose scanning.

Conclusions:

Radionuclide bone imaging is essential for diagnosing and monitoring bone metastases.
Technetium-99m agents facilitate effective low-dose radioisotope scanning.
The technique is valuable for managing metastasis, osteomyelitis, trauma, and osteonecrosis.